Article Text

Download PDFPDF
Initial experience with the CatchView thrombectomy device for acute ischemic stroke
  1. Murat Velioglu1,
  2. Yilmaz Onal1,
  3. Abdulbaki Agackiran2,
  4. Pelin Dogan Ak3,
  5. Hakki Muammer Karakas1
  1. 1Radiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey
  2. 2Radiology, Umraniye Training and Research Hospital, Istanbul, Turkey
  3. 3Neurology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey
  1. Correspondence to Dr Yilmaz Onal, Radiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul 34752, Turkey; dronalylmz{at}gmail.com

Abstract

Background We report our initial experience with the CatchView (CV) thrombectomy device in patients with acute ischemic stroke (AIS).

Methods A retrospective analysis of 53 of 284 AIS patients (mean age 66.6±14.8 years, range 37–94) treated with a CV device between January 2019 and February 2020 was performed. The baseline characteristics (gender, age, comorbidities, National Institutes of Health Stroke Scale (NIHSS) score, intravenous tissue plasminogen activator (IV-tPA) administration, and occlusion localization) of these subjects were recorded. Modified Thrombolysis in Cerebral Ischemia (mTICI) scores of 2b and 3 were considered to indicate successful recanalization, and subjects with a modified Rankin Scale score of ≤2 on day 90 was considered a good clinical outcomes.

Results The mean NIHSS score was 12.3±3. Successful recanalization was achieved in 45 subjects (84.90%), and the rate of good clinical outcomes on day 90 was 43.39%. The secondary distal embolus rate was 5.66%. Symptomatic hemorrhage was observed in 3.77% of the subjects, and the mortality rate was 13.2%.

Conclusions Mechanical thrombectomy devices include a wide array of endovascular tools for removing clots in AIS patients. In terms of successful recanalization and good clinical outcomes on day 90, our initial experience with the CV devices was encouraging.

  • stroke
  • thrombectomy
  • stent
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors All authors have made contributions to this work. All have read and approved the final version of this manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval This study was approved by the local institutional review board.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement Data are available upon reasonable request.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.